ALLOHA-2
Live / Allowed — Approved for publication (as of 08 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 05 May 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99804476
- Mark type
- Stylized text
- Filed
- 05 May 2026
- Attorney of record
- Tiffany D. Gehrke
Goods and services
- Class 005 — Pharmaceuticals: Cells for medical or clinical use for use in the treatment of cancer; pharmaceutical and biopharmaceutical T-cell receptor engineered preparations for use in the treatment of cancer; T-cell therapy products, namely, T-cell receptor engineered cells for medical use in the treatment of cancer
- Class 042 — Scientific and technological services: Pharmaceutical research and development in the field of T-cell therapy for the treatment of cancer; T-cell therapy research services, namely, pharmaceutical and scientific research in the field of treatment of cancer using T-cell receptor engineered T-cell therapies
Owner
- TScan Therapeutics, Inc., Waltham, MA, US
Prosecution history
- 08 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Sept 2026 — ASSIGNED TO EXAMINER
- 03 Sept 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 05 May 2026 — APPLICATION FILING RECEIPT MAILED
- 05 May 2026 — NEW APPLICATION ENTERED